By Kimberly Chin

Gilead Sciences Inc. (GILD) said it expects earnings for fiscal 2020 to be between $5.15 and $5.55 a share.

On an adjusted basis, the biopharmaceutical company expects full-year earnings in the range of $6.05 to $6.45 a share.

The company also projects product sales to be between $21.8 billion and $22.2 billion for the year.

Write to Kimberly Chin at kimberly.chin@wsj.com

(END) Dow Jones Newswires

February 04, 2020 16:36 ET (21:36 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Gilead Sciences Charts.